Patient Safety

Seventy years ago, heparin was first administered for those undergoing surgery, as well as other patients, to reduce the risk of blood clots. Its availability created a revolution in medicine. Today, thousands of Americans rely on heparin each day to survive. Heparin is an essential drug used during open-heart surgery and other conditions for treating and preventing dangerous blood clots, or thrombosis, which can block blood flow to the lungs with sudden and fatal results.

Heparin and other anticoagulant medications, however, are high-alert medications – drugs classified by the Institute for Safe Medication Practices as bearing a heightened risk of causing significant patient harm when they are used in error. Therefore, they must be properly administered to ensure patient safety. In bringing critical products like heparin to market, Fresenius Kabi USA, LLC undergoes a thorough step-by-step process, installing extensive testing and other security measures within every area of the supply chain, to ensure safe delivery to the patient.

Fresenius Kabi USA, LLC has been working closely with healthcare professionals and federal agencies to guarantee that only the safest product is provided to hospitals and to clinicians, and that it is packaged and labeled in the most efficient manner to assure that physicians and clinicians deliver the right dose to the right patient.

For more information on Fresenius Kabi USA, LLC products, please contact Customer Service at (888) 386-1300 between the hours of 7:00 a.m. and 6:00 p.m. CDT.

If you wish to report an adverse event with a Fresenius Kabi USA product please contact the Vigilance Department at (800) 551-7176 (option 4) between the hours of 8 a.m. and 5 p.m. (CST), or e-mail Fresenius Kabi USA Vigilance/Patient Safety at This email address is being protected from spambots. You need JavaScript enabled to view it. .